Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (6)
  • 2024 (3)
  • 2023 (1)
  • 2022 (1)
  • 2021 (4)
  • 2020 (3)

Subject

  • Drug Trafficking (30)
  • Take Back Day (26)
  • Prescription Drugs (23)
  • Outreach/Drug Prevention (22)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Synthetic drugs (14)
  • Congressional Affairs (12)
  • Fake Pills (11)
  • Press Conferences (11)
  • Arrests/Convictions - Major (9)
  • Fentanyl Awareness (9)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • Red Ribbon (9)
  • Guns/Weapons (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Money Laundering (6)
  • One Pill Can Kill (6)
  • OCDETF/Task Force (5)
  • Seizures (Drugs/Property) (5)
  • Extraditions (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Overdose (4)
  • Critical Incident (3)
  • Gangs (3)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Terrorism (2)
  • Counterfeit Pills (1)
  • Dark Web- Internet Trafficking (1)
  • Fentanyl Free America (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Major Law Enforcement Operation (10)
  • Diversion Division (9)

Drug Name

  • Cocaine (5)
  • Fentanyl (5)
  • Methamphetamine (4)
  • Heroin (3)
  • Marijuana (Cannabis) (3)
  • Marijuana Concentrates (2)
  • Opioids (1)
  • Oxycodone (1)
  • Synthetic Opioids (1)

Field Division

  • Washington, DC (150)
  • New York (41)
  • New England (38)
  • Seattle (31)
  • El Paso (30)
  • New Jersey (23)
  • St. Louis (23)
  • Chicago (22)
  • Houston (22)
  • San Francisco (18)
  • Miami (16)
  • Atlanta (15)
  • New Orleans (12)
  • Dallas (10)
  • San Diego (10)
  • Rocky Mountain (9)
  • Phoenix (7)
  • Los Angeles (6)
  • Omaha (4)
  • Louisville (3)
  • Detroit (1)
  • Sede (19)
Clear All Results
19 Results - Showing 1 to 10
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

Operation Vape Trail Cracks Down on Illegal Substances in Vape Shops

WASHINGTON – Today, the Drug Enforcement Administration announced the results of a week-long operational enforcement action as part of a whole-of-government initiative aimed at removing dangerous and illegal vaping substances from communities across America. During the operation, DEA seized more than 2.3 million vape devices and cartridges and more than...
PRESS RELEASE

DEA Surge Targets Sinaloa Cartel Networks Worldwide

WASHINGTON – Today, the Drug Enforcement Administration announced the results of a week-long operational surge aimed at dismantling the Sinaloa Cartel, one of the world’s most violent and powerful drug cartels, responsible for flooding the United States with fentanyl, methamphetamine, cocaine, and heroin. In February, the Trump Administration designated the...
PRESS RELEASE

Trial Victory Secured in Largest Single Fentanyl Pill Bust in DEA History

ALBUQUERQUE – A federal jury convicted an Albuquerque man for his role in a multi-state fentanyl trafficking organization, following an operation that resulted in the largest single fentanyl pill seizure in DEA history. The verdict came after a six-day trial and approximately eight hours of deliberation. The conviction of Alex...
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
PRESS RELEASE

DEA Seizes Record-Breaking 2.7 Million Fentanyl Pills

U.S. Attorney General Pam Bondi joined DEA Leadership, and the men and women of the DEA El Paso Field Division, on Tuesday, May 6, 2025 to announce the single largest seizure of fentanyl pills in DEA history. During an enforcement operation the last week of April, agents from the DEA...
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
PRESS RELEASE

DEA Encourages Communities to Make Every Day Take Back Day

WASHINGTON – The U.S. Drug Enforcement Administration has launched a new campaign encouraging the public to make Every Day Take Back Day by utilizing year-round collection sites to dispose of unneeded and unwanted medications. For more than a decade, DEA has worked with state and local law enforcement partners to...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster